The Biotech Growth Trust PLC (LON:BIOG – Get Rating) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 836.63 ($10.25) and traded as low as GBX 832.06 ($10.20). The Biotech Growth Trust shares last traded at GBX 844 ($10.34), with a volume of 50,821 shares trading hands.
The Biotech Growth Trust Stock Performance
The firm has a market capitalization of £345.38 million and a PE ratio of -1.73. The company has a debt-to-equity ratio of 8.05, a current ratio of 0.00 and a quick ratio of 0.00. The firm has a fifty day moving average price of GBX 836.63 and a 200 day moving average price of GBX 876.26.
In related news, insider Roger Yates bought 10,000 shares of The Biotech Growth Trust stock in a transaction dated Tuesday, June 14th. The stock was acquired at an average cost of GBX 778 ($9.53) per share, with a total value of £77,800 ($95,331.45).
The Biotech Growth Trust Company Profile
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.
- 3 Health Care Stocks in Great Financial Health
- Amazon Names Itself A Top Stock Of Q3 Contender
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Market Fundamentals Drive Results For The Williams Companies
- Are Baidu’s Delisting Fears a Good Entry for New Investors?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.